Curtis Ruegg, EVP, Technical Operations at Revance Therapeutics, Inc. (RVNC), sold 3,000 shares at $30.13 ($91K) on 2015-08-17, disclosed to the SEC on 2015-08-19.
Scheduled sale ($91k) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.13 | 1,000 | $30K | 33.1% |
| 2 | $30.18 | 400 | $12K | 13.3% |
| 3 | $30.27 | 500 | $15K | 16.6% |
| 4 | $30.43 | 500 | $15K | 16.7% |
| 5 | $30.60 | 500 | $15K | 16.8% |
| 6 | $31.35 | 100 |
| $3K |
| 3.4% |
| Total | $30.33 avg | 3,000 | $91K | 100% |
| Filing → |
| RVNC | SELL | 2016-04-13 | $19K | — | Filing → |
| RVNC | SELL | 2016-03-09 | $20K | — | Filing → |
| RVNC | SELL | 2016-02-10 | $18K | — | Filing → |